Nippon Life Global Investors Americas’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
MGP
Nippon Life Global Investors Americas's MDT Position: Q2 2026 in Review
Nippon Life Global Investors Americas reduced its Medtronic (MDT) stake by 3.2% in Q2 2026, selling an estimated $1.27M and leaving 471,190 shares worth $37.2M. The position accounts for 1.48% of the portfolio, ranked #21.
Nippon Life Global Investors Americas first reported a position in MDT in Q1 2014 and has held it in 25 quarters since. The position peaked at $53.1M in Q3 2025. 1,332 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Nippon Life Global Investors Americas held 471,190 shares of Medtronic worth $37.2M as of Q2 2026.
- Nippon Life Global Investors Americas sold 15,800 Medtronic shares in Q2 2026, an estimated $1.27M.
- Medtronic made up 1.48% of Nippon Life Global Investors Americas's portfolio in Q2 2026, its #21 holding.
- Nippon Life Global Investors Americas first reported a position in Medtronic in Q1 2014 and has held it in 25 quarters since.
- Nippon Life Global Investors Americas's Medtronic position peaked at $53.1M in Q3 2025.
- 1,332 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Nippon Life Global Investors Americas's 13F filing for Q2 2026, filed 6 Aug 2026.